HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sunil Krishnan Selected Research

Bevacizumab (Avastin)

1/2016Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.
2/2014Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial.
3/2010Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.
12/2007Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sunil Krishnan Research Topics

Disease

163Neoplasms (Cancer)
01/2024 - 01/2003
30Rectal Neoplasms (Rectal Cancer)
12/2022 - 06/2006
29Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 04/2007
26Adenocarcinoma
11/2022 - 12/2006
22Hepatocellular Carcinoma (Hepatoma)
09/2023 - 04/2008
20Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 12/2006
13Neoplasm Metastasis (Metastasis)
11/2019 - 12/2006
8Hyperthermia
10/2020 - 05/2008
8Stomach Neoplasms (Stomach Cancer)
05/2020 - 01/2008
7Prostatic Neoplasms (Prostate Cancer)
11/2022 - 05/2008
7Breast Neoplasms (Breast Cancer)
11/2021 - 10/2010
7Carcinoma (Carcinomatosis)
07/2014 - 10/2006
6Lymphopenia (Lymphocytopenia)
09/2023 - 01/2018
6Inflammation (Inflammations)
01/2023 - 05/2010
6Anus Neoplasms (Anal Cancer)
01/2018 - 11/2009
5Esophageal Neoplasms (Esophageal Cancer)
01/2023 - 07/2012
5Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2003
5Pathologic Complete Response
01/2018 - 12/2006
4Brain Neoplasms (Brain Tumor)
12/2021 - 01/2003
4Cholangiocarcinoma
09/2021 - 10/2013
4Thrombosis (Thrombus)
01/2021 - 06/2010
4Carcinogenesis
08/2012 - 05/2003
3Hemorrhage
09/2023 - 11/2009
3Liver Diseases (Liver Disease)
09/2023 - 12/2010
3Sarcoma (Soft Tissue Sarcoma)
03/2023 - 01/2005
3Ataxia Telangiectasia (Louis Bar Syndrome)
01/2022 - 02/2015
3Melanoma (Melanoma, Malignant)
01/2022 - 07/2014
3Lung Neoplasms (Lung Cancer)
01/2020 - 01/2016
3Ascites
01/2019 - 09/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 04/2012
3Fatigue
07/2012 - 11/2009
3Leukemia
05/2010 - 01/2009
2Hypoxia (Hypoxemia)
11/2022 - 05/2018
2Body Weight (Weight, Body)
11/2022 - 05/2012
2Necrosis
01/2022 - 01/2011
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2021 - 01/2019
2COVID-19
02/2021 - 11/2020

Drug/Important Bio-Agent (IBA)

30GoldIBA
01/2024 - 11/2007
20Biomarkers (Surrogate Marker)IBA
11/2022 - 08/2008
13Protons (Proton)IBA
09/2023 - 01/2008
12Capecitabine (Xeloda)FDA Link
11/2022 - 10/2006
11MicroRNAs (MicroRNA)IBA
01/2022 - 01/2016
10Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2008
10GemcitabineFDA Link
12/2020 - 04/2007
9Fluorouracil (Carac)FDA LinkGeneric
12/2021 - 10/2006
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 04/2007
7NF-kappa B (NF-kB)IBA
08/2010 - 04/2007
5CurcuminIBA
12/2022 - 04/2007
5Transcription Factors (Transcription Factor)IBA
11/2022 - 04/2008
5Cisplatin (Platino)FDA LinkGeneric
12/2021 - 02/2005
5ErbB Receptors (EGF Receptor)IBA
04/2012 - 01/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2010 - 10/2007
4AntigensIBA
10/2022 - 05/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2009
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 07/2006
4Bevacizumab (Avastin)FDA Link
01/2016 - 12/2007
4Cyclin D1IBA
05/2012 - 04/2007
4Cetuximab (Erbitux)FDA Link
04/2012 - 12/2007
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 08/2010
3RNA (Ribonucleic Acid)IBA
01/2023 - 02/2018
3Lipid NanoparticlesIBA
12/2022 - 02/2020
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 01/2017
3Therapeutic UsesIBA
11/2019 - 09/2012
3Contrast MediaIBA
01/2019 - 03/2009
3Carcinoembryonic AntigenIBA
05/2016 - 05/2007
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2016 - 05/2010
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2012 - 05/2010
3CaspasesIBA
11/2010 - 01/2009
2IonsIBA
01/2024 - 01/2015
2BoronIBA
01/2023 - 08/2019
2RadiopharmaceuticalsIBA
01/2023 - 04/2022
2Docetaxel (Taxotere)FDA Link
12/2022 - 01/2022
2Cathepsin BIBA
12/2022 - 07/2021
2Phosphotransferases (Kinase)IBA
11/2022 - 10/2007
2Lapatinib (GW572016)FDA Link
01/2022 - 05/2015
2Yttrium-90IBA
01/2022 - 12/2007
2salicylhydroxamic acid (SHAM)IBA
12/2021 - 05/2018
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2021 - 05/2010
2GadoliniumIBA
01/2021 - 01/2017

Therapy/Procedure

99Radiotherapy
01/2024 - 01/2003
76Therapeutics
01/2023 - 01/2003
28Drug Therapy (Chemotherapy)
01/2023 - 01/2003
18Neoadjuvant Therapy
12/2021 - 11/2006
11Proton Therapy
03/2023 - 03/2009
8Re-Irradiation
10/2020 - 11/2009
7Heavy Ion Radiotherapy
03/2023 - 01/2015
6Immunotherapy
12/2022 - 09/2014
6Chemoradiotherapy
06/2017 - 12/2006
5Induction Chemotherapy
11/2022 - 07/2007
5Pancreaticoduodenectomy
01/2017 - 03/2008
4Microspheres (Microsphere)
01/2022 - 12/2007
4Aftercare (After-Treatment)
12/2021 - 10/2010
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2019 - 11/2009
3Precision Medicine
10/2020 - 01/2014
3Photothermal Therapy
05/2018 - 01/2012
3Oral Administration
08/2012 - 05/2010
2Liver Transplantation
01/2022 - 06/2010
2Segmental Mastectomy (Lumpectomy)
01/2022 - 03/2012
2Palliative Care (Palliative Therapy)
12/2021 - 12/2006
2Boron Neutron Capture Therapy
01/2021 - 08/2019